BROAD INSTITUTE INC. for BROAD INSTITUTE INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAMRATA SENGUPTA New | — |
Science/Technology SCI
- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAMRATA SENGUPTA New | — |
Medical/Disease Research/Clinical Labs MED
- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAMRATA SENGUPTA New | — |
Defense DEF
- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAMRATA SENGUPTA New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.